Mascoma Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Mascoma Wealth Management's MDT Position: Q3 2026 in Review
Mascoma Wealth Management reduced its Medtronic (MDT) stake by 24% in Q3 2026, selling an estimated $353 and leaving 13 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #491.
Mascoma Wealth Management first reported a position in MDT in Q4 2016 and has held it in 26 quarters since. The position peaked at $67K in Q1 2017. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Mascoma Wealth Management held 13 shares of Medtronic worth $1.12K as of Q3 2026.
- Mascoma Wealth Management sold 4 Medtronic shares in Q3 2026, an estimated $353.
- Medtronic made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q3 2026, its #491 holding.
- Mascoma Wealth Management first reported a position in Medtronic in Q4 2016 and has held it in 26 quarters since.
- Mascoma Wealth Management's Medtronic position peaked at $67K in Q1 2017.
- 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Mascoma Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.